Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)

Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer

NCT07156045 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer

NCT04049747 ·Status: COMPLETED ·Phase: NA

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

NCT03436654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

NCT05790213 ·Status: RECRUITING ·Phase: PHASE2

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT

NCT05983198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

NCT05354375 ·Status: RECRUITING ·Phase: PHASE1

Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer

NCT03077659 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

NCT05707468 ·Status: NOT_YET_RECRUITING ·Phase: NA

Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC

NCT03085966 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer

NCT00551044 ·Status: COMPLETED ·Phase: NA

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

NCT05076851 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

NCT06609005 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154

NCT00535834 ·Status: COMPLETED

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

NCT01123434 ·Status: COMPLETED

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

NCT03692663 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

NCT05658003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT05352178 ·Status: RECRUITING ·Phase: PHASE3

SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation

NCT04486937 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma

NCT03061643 ·Status: UNKNOWN ·Phase: PHASE2

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

NCT05212857 ·Status: UNKNOWN ·Phase: PHASE2

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

NCT03081481 ·Status: COMPLETED ·Phase: PHASE2

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961 ·Status: COMPLETED

CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

NCT06306612 ·Status: RECRUITING ·Phase: NA

Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer

NCT06441994 ·Status: RECRUITING ·Phase: PHASE1

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

NCT04034095 ·Status: COMPLETED